WYNFIDRA

Serial Number 97531542
605

Registration Progress

Application Filed
Aug 3, 2022
Under Examination
Approved for Publication
Jun 11, 2024
Published for Opposition
Jun 11, 2024
Registered

Basic Information

Serial Number
97531542
Filing Date
August 3, 2022
Published for Opposition
June 11, 2024
Abandonment Date
June 12, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
605
Status Date
Jun 13, 2024

Rights Holder

Verona Pharma PLC

99
Address
One Central Square
Cardiff CF101FS
GB

Ownership History

Verona Pharma PLC

Original Applicant
99
Cardiff GB

Verona Pharma PLC

Owner at Publication
99
Cardiff GB

Legal Representation

Attorney
Robert B.G. Horowitz, Esq.
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUBE Jul 11, 2024 361 days overdue Medium Until Aug 11, 2024

Application History

17 events
Date Code Type Description
Jun 13, 2024 MAB5 E ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Jun 13, 2024 ABN5 O ABANDONMENT - AFTER PUBLICATION
Jun 12, 2024 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED
Jun 11, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 PUBO A PUBLISHED FOR OPPOSITION
May 22, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 24, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2023 ALIE A ASSIGNED TO LIE
May 24, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 22, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 22, 2023 GNSL F LETTER OF SUSPENSION E-MAILED
May 22, 2023 CNSL R SUSPENSION LETTER WRITTEN
May 22, 2023 DOCK D ASSIGNED TO EXAMINER
Aug 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2022 NWAP I NEW APPLICATION ENTERED

Active Deadlines

Notice of Publication
Due: Jul 11, 2024 Overdue